Exploratory/pilot studies are a key tool in the drug development. Their main goal is to identify and define efficacy, tolerability, potential toxic effects and to provide data for identification of clinical doses.

Target Animal Safety Studies (TAS) are a key part of veterinary drug development. Their main objective is to verify that the product is safe for the animals for which it is intended, at the recommended dosage, route of administration and duration of treatment.

Bioequivalence studies (BEQ studies) are crucial for the development and approval of generic drugs. Their main goal is to demonstrate that the generic drug has the same bioavailability as the original drug, which means that it behaves the same way in the body - that is, it has the same rate and extent of absorption.

Immersion and wash-out studies play an important role in evaluating the efficacy and safety of spot-on products (e.g., antiparasitics applied to the skin of animals). These studies help simulate real-world conditions to which an animal may be exposed and verify whether the product remains effective after contact with water or after a period of non-application

Wipe tests in the context of spot-on products (e.g. antiparasitics applied to the skin of animals) are used to assess possible contamination of the surrounding environment or contact with humans after application of the product. This is an adapted method for monitoring residues of the active substance on the surface of the animal's fur or skin.